146 related articles for article (PubMed ID: 36572567)
21. Prediction of human pharmacokinetics--gut-wall metabolism.
Fagerholm U
J Pharm Pharmacol; 2007 Oct; 59(10):1335-43. PubMed ID: 17910807
[TBL] [Abstract][Full Text] [Related]
22. Presentation of a structurally diverse and commercially available drug data set for correlation and benchmarking studies.
Sköld C; Winiwarter S; Wernevik J; Bergström F; Engström L; Allen R; Box K; Comer J; Mole J; Hallberg A; Lennernäs H; Lundstedt T; Ungell AL; Karlén A
J Med Chem; 2006 Nov; 49(23):6660-71. PubMed ID: 17154497
[TBL] [Abstract][Full Text] [Related]
23. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models.
Sjögren E; Thörn H; Tannergren C
Mol Pharm; 2016 Jun; 13(6):1763-78. PubMed ID: 26926043
[TBL] [Abstract][Full Text] [Related]
24. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
[TBL] [Abstract][Full Text] [Related]
25. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry.
Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW
Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631
[TBL] [Abstract][Full Text] [Related]
26. Predicting the Pharmacokinetics of Orally Administered Drugs across BCS Classes 1-4 by Virtual Bioequivalence Model.
Zhang F; Wu X; Wu K; Yu M; Liu B; Wang H
Mol Pharm; 2023 Jan; 20(1):395-408. PubMed ID: 36469444
[TBL] [Abstract][Full Text] [Related]
27. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
[TBL] [Abstract][Full Text] [Related]
28. IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes.
Darwich AS; Margolskee A; Pepin X; Aarons L; Galetin A; Rostami-Hodjegan A; Carlert S; Hammarberg M; Hilgendorf C; Johansson P; Karlsson E; Murphy D; Tannergren C; Thörn H; Yasin M; Mazuir F; Nicolas O; Ramusovic S; Xu C; Pathak SM; Korjamo T; Laru J; Malkki J; Pappinen S; Tuunainen J; Dressman J; Hansmann S; Kostewicz E; He H; Heimbach T; Wu F; Hoft C; Pang Y; Bolger MB; Huehn E; Lukacova V; Mullin JM; Szeto KX; Costales C; Lin J; McAllister M; Modi S; Rotter C; Varma M; Wong M; Mitra A; Bevernage J; Biewenga J; Van Peer A; Lloyd R; Shardlow C; Langguth P; Mishenzon I; Nguyen MA; Brown J; Lennernäs H; Abrahamsson B
Eur J Pharm Sci; 2017 Jan; 96():626-642. PubMed ID: 27693299
[TBL] [Abstract][Full Text] [Related]
29. Predictive Modelling in pharmacokinetics: from in-silico simulations to personalized medicine.
Paliwal A; Jain S; Kumar S; Wal P; Khandai M; Khandige PS; Sadananda V; Anwer MK; Gulati M; Behl T; Srivastava S
Expert Opin Drug Metab Toxicol; 2024 Apr; 20(4):181-195. PubMed ID: 38480460
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Physiologically Based Pharmacokinetic Models to Predict the Absorption of BCS Class I Drugs in Different Pediatric Age Groups.
Liu XI; van den Anker JN; Burckart GJ; Dallmann A
J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S94-S107. PubMed ID: 34185902
[TBL] [Abstract][Full Text] [Related]
31. Predicting when biliary excretion of parent drug is a major route of elimination in humans.
Hosey CM; Broccatelli F; Benet LZ
AAPS J; 2014 Sep; 16(5):1085-96. PubMed ID: 25004821
[TBL] [Abstract][Full Text] [Related]
32. In Silico Models of Human PK Parameters. Prediction of Volume of Distribution Using an Extensive Data Set and a Reduced Number of Parameters.
Lombardo F; Bentzien J; Berellini G; Muegge I
J Pharm Sci; 2021 Jan; 110(1):500-509. PubMed ID: 32891631
[TBL] [Abstract][Full Text] [Related]
33. A novel strategy for physiologically based predictions of human pharmacokinetics.
Jones HM; Parrott N; Jorga K; Lavé T
Clin Pharmacokinet; 2006; 45(5):511-42. PubMed ID: 16640456
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Oral Bioavailability in Rats: Transferring Insights from in Vitro Correlations to (Deep) Machine Learning Models Using in Silico Model Outputs and Chemical Structure Parameters.
Schneckener S; Grimbs S; Hey J; Menz S; Osmers M; Schaper S; Hillisch A; Göller AH
J Chem Inf Model; 2019 Nov; 59(11):4893-4905. PubMed ID: 31714067
[TBL] [Abstract][Full Text] [Related]
35. The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.
Fagerholm U
Pharm Res; 2008 Mar; 25(3):625-38. PubMed ID: 17710514
[TBL] [Abstract][Full Text] [Related]
36. In Silico Prediction of Human Intravenous Pharmacokinetic Parameters with Improved Accuracy.
Wang Y; Liu H; Fan Y; Chen X; Yang Y; Zhu L; Zhao J; Chen Y; Zhang Y
J Chem Inf Model; 2019 Sep; 59(9):3968-3980. PubMed ID: 31403793
[TBL] [Abstract][Full Text] [Related]
37. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.
Tsume Y; Mudie DM; Langguth P; Amidon GE; Amidon GL
Eur J Pharm Sci; 2014 Jun; 57():152-63. PubMed ID: 24486482
[TBL] [Abstract][Full Text] [Related]
38. The in silico prediction of human-specific metabolites from hepatotoxic drugs.
Valerio LG; Long A
Curr Drug Discov Technol; 2010 Sep; 7(3):170-87. PubMed ID: 20843294
[TBL] [Abstract][Full Text] [Related]
39. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
40. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.
Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B
Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
